To view the PDF file, sign up for a MySharenet subscription.

NUMERAL LIMITED - Numeral Agrees to Acquire an Effective 51% Shareholding in Longevity Lab (Pty) Ltd

Release Date: 02/12/2024 10:30
Code(s): XII     PDF:  
Wrap Text
Numeral Agrees to Acquire an Effective 51% Shareholding in Longevity Lab (Pty) Ltd

NUMERAL LTD
(formerly Go Life International Ltd)
(Incorporated in the Republic of Mauritius)
(Registration number: 098177 C1/GBL)
Primary Listing SEM share code: GOLI.N0000
Secondary Listing JSE share code: XII
ISIN: MU0330N00004
("the Company" or "Numeral")

NUMERAL AGREES TERMS TO ACQUIRE AN EFFECTIVE 51% SHAREHOLDING IN LONGEVITY LAB (PTY) LTD
("LONGEVITY")

Shareholders are advised that Numeral and Longevity have signed terms for Numeral to acquire an effective
51% of Longevity through an issue of ordinary shares in Longevity for cash ("the Transaction").

Longevity is a biotechnology business specialising in creating and managing discerningly appointed, world
class wellness clinics and holistic wellness programs that incorporate nurse and doctor administered, leading
stem cell and cellular optimisation medical treatments, through intravenous therapy protocols aimed at
cellular detoxification, reduction in overall body inflammation and optimization of cellular health. Treatment
packages include, inter alia, glutathione, vitamin drips, NAD drips, PRP treatments, stem cell treatments,
health plans and health mentorship.

The acquisition is aligned with Numeral's strategy of building a fully vertically integrated biotechnology group,
which will remain a key focus for the Numeral Board.

The transaction is subject to successful conclusion of the following conditions precedent:

•      Relevant regulatory approvals, to the extent required;
•      Signature of the full suite of transaction agreements;
•      Due diligence to the satisfaction of the Numeral board; and
•      Resolutions by the boards of both Parties approving the Transaction.

The Transaction falls outside of the Disclosable Transaction threshold of the SEM Listings Rules.

This communiqué is issued pursuant to SEM Listing Rules 11.3, 12.14 and 12.20 and section 88 of the Securities
Act of Mauritius 2005 as well as the JSE Listings Requirements. The Board accepts full responsibility for the
accuracy of the information contained in this announcement.

Numeral has its primary listing on the SEM and a secondary listing on the Alternative Exchange of the JSE.

For and on behalf of the board
Mauritius
2 December 2024

Executive Directors:                                                               Non-Executive Directors:
Dave van Niekerk                                                                    Mohamed Yusuf Sooklall
Neville Graham                                                                       Dr Aansa Devi Bedacee

JSE Sponsor:                                                      Management Company and Company Secretary:
AcaciaCap Advisors Proprietary Limited                                     LTS Management Services Limited

Date: 02-12-2024 10:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.